Clinical Trials on BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms

Total 3767 results

EMS

Completed

Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria

Dysuria

Brazil
Vantia Ltd
Veeda Clinical Research

Completed

Efficacy and Safety of VA106483 in Elderly Males

Nocturia

United Kingdom
Ferring Pharmaceuticals

Completed

An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults

Nocturia

United States, Canada
Vantia Ltd

Completed

Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon

Nocturia

Germany
Ferring Pharmaceuticals

Completed

A Study of Minirin Melt in Patients With Nocturia

Nocturia

Czech Republic
Ferring Pharmaceuticals

Completed

Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men (NOC)

Nocturia

Japan
Astellas Pharma Inc

Completed

A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (ARIES)

Urinary Bladder, Overactive

United States, Canada
Astellas Pharma Inc

Completed

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (SCORPIO)

Urinary Bladder, Overactive

Australia, Belgium, France, Spain, Sweden, Bulgaria, Romania, Italy, Greece, South Africa, Austria, Poland, United Kingdom, Hungary, Denmark, Netherlands, Switzerland, Ireland, Lithuania, Russian Federation, Germany, Latvia, Slovakia, Finlan... and more
Astellas Pharma Inc

Completed

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (TAURUS)

Urinary Bladder, Overactive

Canada, Poland, Belgium, Spain, Sweden, United States, Romania, Italy, France, Austria, United Kingdom, Germany, Hungary, Australia, Denmark, Netherlands, Switzerland, Lithuania, Russian Federation, Latvia, South Africa, Slovakia, F... and more
Astellas Pharma Inc

Completed

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (CAPRICORN)

Urinary Bladder, Overactive

United States, Hungary, Canada, Spain, Finland, Slovakia, Czechia, Sweden, Germany, Denmark, Norway
Astellas Pharma Europe B.V.

Completed

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder (Blossom)

Urinary Bladder, Overactive

Belgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
Medway NHS Foundation Trust

Completed

A Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive Bladder

Urogynaecology

United Kingdom
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Completed

Behavioural Therapy Program for Female Overactive Bladder

Urinary Bladder, Overactive

Turkey
Bayer

Completed

A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function

Overactive Bladder | Detrusor Overactivity

Spain, Belgium, Canada, Netherlands, Switzerland, Russian Federation, Germany, Israel, Hungary, Portugal, France, Poland, Czech Republic
National Taiwan University Hospital

Completed

Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome

Antimuscarinic Drug

Taiwan
Pfizer

Completed

Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder

Urinary Bladder, Overactive

Australia, France, Colombia, Germany, Canada, Finland, Slovakia, Spain, Switzerland, Italy, Chile, Greece, Latvia, Norway, Poland, United Kingdom
Astellas Pharma Inc

Completed

A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients

Urinary Bladder, Overactive

China
Loyola University
Kimberly-Clark Corporation

Completed

Investigation of the Effect of the Female Urinary Microbiome on Incontinence (FUM)

Overactive Bladder | Nocturia | Incontinence

United States
Loma Linda University

Completed

"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"

Overactive Bladder | Menopause | Caffeine

United States
Astellas Pharma Inc

Completed

Specified Drug Use-results Survey of Betanis Tablets

Overactive Bladder

Japan
Astellas Pharma Inc

Completed

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

Urinary Bladder, Overactive

China, Taiwan, India, Korea, Republic of
Allergan

Completed

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

Overactive Bladder | Pharmacokinetics | Elderly

United States
Astellas Pharma Europe Ltd.

Terminated

An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics

Overactive Bladder | Healthy Subjects

Netherlands
Allergan

Completed

Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence

Urinary Bladder, Overactive

France, United States, Netherlands
Boston Scientific Corporation

Completed

An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome

Overactive Bladder

United States
Pfizer

Completed

A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder. (SOFIA)

Urinary Bladder, Overactive

Portugal, Spain, Turkey, Finland, Germany, Norway, Sweden, Slovakia, Italy, Austria, United Kingdom, Belgium, Denmark, Israel, Switzerland
Stony Brook University

Recruiting

Single Versus Double Suture Cervical Cerclage to Prevent Preterm Birth

The Primary Outcome is Preterm Delivery Before 28 Weeks Gestational Age Compared to Women With One vs Two Cerclages Placed

United States
University Hospital, Ghent

Recruiting

Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women (HARALD)

Nocturia

Belgium
Ferring Pharmaceuticals

Terminated

Study of Minirin Melt® in Adult Patients With Nocturia

Nocturia

Korea, Republic of
Serenity Pharmaceuticals, Inc.

Completed

Long Term Safety Assessment of SER120 in Patients With Nocturia

Nocturia

United States
Serenity Pharmaceuticals, Inc.

Completed

Study to Investigate the Safety and Pharmacokinetics of SER120 Nasal Spray in Elderly Patients With Nocturia

Nocturia

United States
Serenity Pharmaceuticals, Inc.

Completed

Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4 (DB4)

Nocturia

United States
Ferring Pharmaceuticals

Completed

Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women (NOC)

Nocturia

Japan
Ferring Pharmaceuticals

Completed

A Study of Minirin Melt in Patients With Nocturia

Nocturia

Czech Republic
Ferring Pharmaceuticals

Completed

Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo (NOC)

Nocturia

Japan
Vantia Ltd

Completed

VA106483 Dose Response in Females

Nocturia

United States
Vantia Ltd

Completed

VA106483 and Alpha Blocker Interaction Study in Elderly Males

Nocturia

United Kingdom
Mansoura University

Not yet recruiting

Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children

Overactive Bladder | Voiding Disorders
University of California, Irvine

Completed

Comparison of Motor and Sensory Response With Interstim Stimulation

Overactive Bladder | Urgency-Frequency

United States
GlaxoSmithKline

Completed

Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder

Urinary Bladder, Overactive

Japan
Astellas Pharma Europe B.V.

Completed

A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)

Pediatric | Neurogenic Detrusor Overactivity

United States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
NHS Greater Glasgow and Clyde
Glasgow Caledonian University; University of Glasgow

Unknown

TPTNS: Home vs Hospital Treatment for Overactive Bladder

Overactive Bladder | Detrusor, Overactive

United Kingdom
Astellas Pharma Europe Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. (BEYOND)

Urologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases

Greece, Ireland, Armenia, Austria, Belarus, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Hungary, Italy, Kazakhstan, Latvia, Lebanon, Lithuania, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovaki... and more
University of North Carolina, Chapel Hill
American Urogynecologic Society

Completed

The Effect of Anticholinergics on Cognitive Function in the Elderly (ACE)

Urinary Bladder, Overactive | Cognitive Function | Mental Competency

United States
Astellas Pharma Inc

Completed

Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. (SHRINK)

Overactive Bladder | Detrusor Overactivity

Belgium, Norway, Spain, Sweden, Italy, Czech Republic, Hungary, France, Canada, Germany, Austria, United Kingdom, Bulgaria, Russian Federation, United States, Poland, Slovakia, Turkey, Israel, Romania
Astellas Pharma Inc

Completed

A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

Urinary Bladder, Overactive

Japan
Maastricht University Medical Center

Unknown

Brain Areas Involved in Bladder Filling and Contraction

Urinary Bladder, Overactive

Netherlands
BioSerenity

Completed

Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans (DETTECH) (DETTECH)

Urinary Bladder Diseases | Urinary Incontinence | Urinary Disorders

France
Universiti Sains Malaysia

Completed

Effects of Ranibizumab in Primary Pterygium Surgery

Patients With Primary Nasal Pterygium

Malaysia
Assiut University

Not yet recruiting

Protocols for Prevention of PPH During CS in High Risk Group

Atonic PPH

Clinical Trials on BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations